Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Allena Pharmaceuticals
One Newton Executive Park, Suite 202
Newton, MA 02462
Phone: 617-467-4577
http://www.allenapharma.com/

Allena Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases. Allena's lead program, ALLN-177, is in an ongoing Phase 2 clinical trial in patients with hyperoxaluria. The company's proven approach enables the design and development of oral protein therapies that remain in the gastrointestinal (GI) tract, where the protein exerts its therapeutic effect by reducing toxic metabolites without being absorbed into the bloodstream. Led by a proven management team with deep expertise in protein therapeutic design and development, Allena is committed to bringing new breakthrough treatments to patients with unmet medical needs. Based in Newton, Mass., the company is backed by top-tier venture investors including Frazier Healthcare, Third Rock Ventures, HBM Partners, Bessemer Venture Partners and Pharmstandard International.

Key Contact
Name
Alexey Margolin
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/04/14 $25,000,000 Series B Frazier Healthcare
HBM Partners
Pharmstandard International
Third Rock Ventures
undisclosed
12/09/15 $53,000,000 Series C Fidelity Investments
Frazier Healthcare
HBM BioCapital
Partner Fund Management
Wellington Management Company
undisclosed


Featured Reading